Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

2 drugs in development

Preclinical2

By Therapeutic Area

top 1

Hematology

2100%

R&D Momentum

49/100

Pipeline Velocity

15/100

Trial Completion Rate

80/100

Pipeline Concentration

100/100

Pipeline Freshness

36/100

Activity

Recent Activity

Last 14 days

Jul 11, 2026

Completed

Cord Blood Platelet Poor Plasma Eye Drops

Jul 3, 2026

Active, not recruiting

Satisfaction of Patients With Erectile Dysfunction With the Use of Sildenafil Oral Suspension Compared to Orodispersible Tablets

Earlier

Jun 27, 2026TrialEfficacy and Tolerability of Treatment With Alfalitic Plus Serenoa Repens Compared to Alfalitic Plus Antimuscarinic for Moderate-severe Mixed Lower Urinary Tract Symptoms: Results of a Cross-sectional Clinical Study

Aug 11, 2025TrialUltra-Safe Hormonal Strategy: Transdermal Estradiol Added to Progestins for Endometriosis

Oct 1, 2024TrialIMPACT OF KIDNEY FAILURE ON THE REGULATION OF HUMORAL RESPONSE TO VACCINATION

Sep 1, 2024TrialImmunological and Virological Characterization of Patients With Chronic HBV-HDV Infection: Outcomes and Response to Bulevirtide Treatment

May 6, 2024TrialEffectiveness and Clinical Outcomes of Long-term Bulevirtide Monotherapy in Patients With HDV-related Compensated Cirrhosis

Feb 1, 2024TrialPembrolizumab Plus Lenvatinib in Previously Treated Classic Kaposi Sarcoma

4 more events

Jan 1, 2024TrialDRACULA1 Partum Depression: an Integrated Molecular-pharmaco-imaging Study")

Oct 8, 2023TrialPrenatal Antibiotics and Breast Milk / Neonatal IgA

May 1, 2023TrialEffectiveness and Safety of Bulevirtide (BLV) Therapy in Patients With Chronic Hepatitis Delta (CHD) in Italy (D-SHIELD)

Apr 1, 2023TrialEfficacy and Safety of Bulevirtide (BLV) Therapy in HDV Chronic Hepatitis (CHD) in Italy

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Pipeline

Drug Pipeline

Indication

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Hematology

Immune Thrombocytopenia

Fecal microbiome cytokine essays

Hematology

Immune Thrombocytopenia

Fecal microbiomePreclinical

cytokine essaysPreclinical

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)